Steven Powell is the founder of eTheRNA immunotherapies. eTheRNA immunotherapies has raised $63M in total funding. Latest round: Series B.
Steven Powell is a biotechnology executive who previously served as CEO of the Belgian clinical-stage company eTheRNA Immunotherapies, guiding it through multiple funding rounds. He has since transitioned to CEO of Ribonexus and holds a Non-Executive Director role at eTheRNA.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide